Juliet Gray

Professor Juliet Gray is a Paediatric Oncologist at the Centre for Cancer Immunology, University of Southampton.

She is the clinical lead of the Southampton Paediatric Oncology unit and also leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials. Her specific research interests include anti-GD2 and immunomodulatory antibodies, such as those targeting PD-1.

She leads a number of immunotherapy clinical trials, including the MINIVAN trial, a transatlantic phase I trial, combining targeted radiation therapy and two immune therapies (131-I MIBG, Nivolumab and dinutuximab beta) for the treatment of children with relapsed or refractory neuroblastoma. Professor Gray is Chair of the UK Neuroblastoma group and SIOPEN Clinical Trials Committee and is co-chair of the SIOPEN Immunotherapy committee.

She is representative of the Clinical Trials Committee within the SIOPEN Exectuve Committee from 2024 on.